175 related articles for article (PubMed ID: 12010048)
21. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of Drosophila sialyltransferase.
Koles K; Irvine KD; Panin VM
J Biol Chem; 2004 Feb; 279(6):4346-57. PubMed ID: 14612445
[TBL] [Abstract][Full Text] [Related]
24. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
25. Enabling Chemoenzymatic Strategies and Enzymes for Synthesizing Sialyl Glycans and Sialyl Glycoconjugates.
Chen X
Acc Chem Res; 2024 Jan; 57(2):234-246. PubMed ID: 38127793
[TBL] [Abstract][Full Text] [Related]
26. Porcine liver (2-->3)-alpha-sialyltransferase: substrate specificity studies and application of the immobilized enzyme to the synthesis of various sialylated oligosaccharide sequences.
Lubineau A; Basset-Carpentier K; Augé C
Carbohydr Res; 1997 May; 300(2):161-7. PubMed ID: 9203341
[TBL] [Abstract][Full Text] [Related]
27. Characterization of mouse sialyltransferase genes: their evolution and diversity.
Takashima S
Biosci Biotechnol Biochem; 2008 May; 72(5):1155-67. PubMed ID: 18460788
[TBL] [Abstract][Full Text] [Related]
28. Specificity of human natural antibodies referred to as anti-Tn.
Dobrochaeva K; Khasbiullina N; Shilova N; Antipova N; Obukhova P; Ovchinnikova T; Galanina O; Blixt O; Kunz H; Filatov A; Knirel Y; LePendu J; Khaidukov S; Bovin N
Mol Immunol; 2020 Apr; 120():74-82. PubMed ID: 32087569
[TBL] [Abstract][Full Text] [Related]
29. Alterations of O-glycan biosynthesis in human colon cancer tissues.
Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
[TBL] [Abstract][Full Text] [Related]
30. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
31. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
32. Dependence of the bi-functional nature of a sialyltransferase from Neisseria meningitidis on a single amino acid substitution.
Wakarchuk WW; Watson D; St Michael F; Li J; Wu Y; Brisson JR; Young NM; Gilbert M
J Biol Chem; 2001 Apr; 276(16):12785-90. PubMed ID: 11278878
[TBL] [Abstract][Full Text] [Related]
33. Mucin-type O-glycans in tears of normal subjects and patients with non-Sjögren's dry eye.
Guzman-Aranguez A; Mantelli F; Argüeso P
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4581-7. PubMed ID: 19407012
[TBL] [Abstract][Full Text] [Related]
34. Efficient chemoenzymatic synthesis of novel galacto-N-biose derivatives and their sialylated forms.
Li L; Liu Y; Li T; Wang W; Yu Z; Ma C; Qu J; Zhao W; Chen X; Wang PG
Chem Commun (Camb); 2015 Jun; 51(51):10310-3. PubMed ID: 26023910
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a multifunctional α2,3-sialyltransferase from Pasteurella dagmatis.
Schmölzer K; Ribitsch D; Czabany T; Luley-Goedl C; Kokot D; Lyskowski A; Zitzenbacher S; Schwab H; Nidetzky B
Glycobiology; 2013 Nov; 23(11):1293-304. PubMed ID: 23969291
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes.
Takashima S; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Nov; 277(48):45719-28. PubMed ID: 12235148
[TBL] [Abstract][Full Text] [Related]
37. Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1-4)GlcNAc-R alpha 2,6-sialyltransferase alpha 2,6-linked NeuAc is preferentially attached to the Gal(beta 1-4)GlcNAc(beta 1-2)Man(alpha 1-3)-branch of diantennary oligosaccharides from secreted recombinant beta-trace protein.
Grabenhorst E; Hoffmann A; Nimtz M; Zettlmeissl G; Conradt HS
Eur J Biochem; 1995 Sep; 232(3):718-25. PubMed ID: 7588709
[TBL] [Abstract][Full Text] [Related]
38. Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family.
Wen DX; Livingston BD; Medzihradszky KF; Kelm S; Burlingame AL; Paulson JC
J Biol Chem; 1992 Oct; 267(29):21011-9. PubMed ID: 1400416
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and expression of chick embryo Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase. Comparison with the mammalian enzyme.
Kurosawa N; Kawasaki M; Hamamoto T; Nakaoka T; Lee YC; Arita M; Tsuji S
Eur J Biochem; 1994 Jan; 219(1-2):375-81. PubMed ID: 8307003
[TBL] [Abstract][Full Text] [Related]
40. Chemoenzymatic synthesis of the oligosaccharide moiety of the tumor-associated antigen disialosyl globopentaosylceramide.
't Hart IME; Li T; Wolfert MA; Wang S; Moremen KW; Boons GJ
Org Biomol Chem; 2019 Aug; 17(31):7304-7308. PubMed ID: 31339142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
